Arrowhead Pharmaceuticals Inc (ARWR) — Capital Reinvestment Ratio
Arrowhead Pharmaceuticals Inc (ARWR) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow ($20.49 Million) in capital expenditures ($7.49 Million). Check how tangible is Arrowhead Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Arrowhead Pharmaceuticals Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Arrowhead Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see ARWR cash flow conversion.
Annual Capital Reinvestment Ratio for Arrowhead Pharmaceuticals Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Arrowhead Pharmaceuticals Inc from 2019 to 2025. See how much free cash does Arrowhead Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | $179.55 Million | $22.67 Million | ▼ -8.3% |
| 2021 | 0.14x | $171.22 Million | $23.57 Million | ▲ +98.4% |
| 2019 | 0.07x | $173.03 Million | $12.00 Million | — |